ADORA2A and neoplasm: Research by Dr. Ohta and Dr. Sitkovsky has shown that, the A2AR has nonredundant functions in suppressing inflammation and reducing tissue damage, and has suggested that regulation of adenosine/A2AR signaling pathway could be a strategy for tumor therapy.5, 6